procyanidin b2 has been researched along with Allergic Encephalomyelitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aso, H; Endo, K; Haga, H; Isono, M; Makabe, H; Masaki, A; Niitsuma, F; Rizeq, L; Saiki, T; Sawa, T; Tanaka, S; Tanaka, Y | 1 |
1 other study(ies) available for procyanidin b2 and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Oral administration of procyanidin B2 3,3"-di-O-gallate ameliorates experimental autoimmune encephalomyelitis through immunosuppressive effects on CD4
Topics: Administration, Oral; Animals; CD4-Positive T-Lymphocytes; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Glycolysis; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Proanthocyanidins; T-Lymphocytes | 2023 |